News | June 22, 2009

Study Compares Mammo Plus Automated Breast Ultrasound to Mammography Alone

June 22, 2009 - U-Systems, a dedicated breast ultrasound systems manufacturer, together with Medical Director Jessica A. Guingrich, M.D., of OSF Saint Francis Medical Center, Susan G. Komen Breast Center and Centers for Breast Health have initiated the SOMO·INSIGHT Clinical Study, designed to examine whether digital mammography along with the somo•v Automated Breast Ultrasound (ABUS) is more sensitive to detecting breast lesions when compared to mammography alone in women with dense breasts.

The first participants have been enrolled and the first pathologically confirmed cancer has been detected in a mammographically-negative screening patient. The initiation of this nationwide study, which intends to recruit over 20,000 women, is an important milestone for U-Systems in evaluating new approaches to improved cancer detection. Screening mammography can be limited in women with dense breasts and these women have a higher risk of breast cancer. ABUS uses ultrasound (sound waves) at a reportedly safe frequency to create images of the internal breast tissue, unlike mammography, which uses radiation. Ultrasound has been shown to find cancer not visible with mammography in women who have dense breasts. A new approach to improving breast cancer detection is critical for women with dense breasts who undergo mammography. It is for this reason that U-Systems developed the somo•v and is sponsoring the SOMO·INSIGHT clinical study.

Jessica A. Guingrich, M.D., principal investigator for the SOMO·INSIGHT Clinical Study at OSF stated, “We are excited to be a part of this clinical study and to be able to bring new technology for earlier cancer detection to our patients. Shortly after initiating the clinical study, we identified the first pathologically-confirmed cancer in a mammographically negative patient. Fortunately, the patient was enrolled in the SOMO·INSIGHT study and the somo•v Automated Breast Ultrasound identified a region of interest which was confirmed on biopsy to be an Infiltrating Ductal Carcinoma of the Breast. The patient is now undergoing treatment for this cancer.”

For more information: www.u-systems.com and www.osfhealthcare.org

Related Content

Sponsored Content | Videos | Breast Imaging | July 28, 2017
Nancy Cappello, Ph.D., executive director and founder of Are You Dense Inc. and Are You Dense Advocacy, explains how
Philips Introduces New OB/GYN Ultrasound Innovations for Epiq and Affiniti Systems
News | Ultrasound Womens Healthcare | May 10, 2017
Philips announced the debut of its TrueVue, GlassVue and aRevealA.I. capabilities on the company’s Epiq 7 and 5 and...
Hitachi Aloka, Sofia 3-D Breast Ultrasound, Innovative Technology Designation, Vizient Inc., RSNA 2016
News | Ultrasound Womens Healthcare | January 13, 2017
January 13, 2017 — Hitachi Aloka Medical America Inc.
Technology | Computer-Aided Detection Software | December 07, 2016
QView Medical Inc. announced that it received U.S. Food and Drug Administration (FDA) approval in early November for...
Hitachi Aloka Medical America, Arietta ultrasound, iVu, Sofia whole-breast imaging system, RSNA 2016
Technology | Ultrasound Womens Healthcare | September 30, 2016
Hitachi Aloka Medical America recently announced the support of its Arietta 70 and Arietta 60 ultrasound systems with...
SonoCiné, 3-D multiplanar reconstruction software, Automated Whole Breast Ultrasound, AWBUS
Technology | Ultrasound Womens Healthcare | July 20, 2016
SonoCiné recently unveiled new 3-D whole breast multiplanar reconstruction software to improve early detection of...
ultrasound guidance, thoracic paravertebral nerve block, TPVB, mastectomy, Peter Stefanovich
News | Ultrasound Womens Healthcare | January 15, 2016
January 15, 2016 — A regional anesthesia technique called thoracic paravertebral nerve block (TPVB) is highly effecti
Breast ultrasound, ABUS
Feature | Breast Imaging | December 29, 2015
December 29, 2015 - The use of ultrasound (US) in detecting breast cancer has been shown to be comparable in its sens
Seno Medical, Imagio breast imaging system, opto-acoustic device, PIONEER Study, pilot data, RSNA 2015
News | Ultrasound Womens Healthcare | December 22, 2015
Seno Medical Instruments Inc. announced results of its pilot study portion of the PIONEER pivotal study at the 2015...
Overlay Init